These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24142230)

  • 1. Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells.
    Ben-Horin S; Polak-Charcon S; Barshack I; Picard O; Fudim E; Yavzori M; Avivi C; Mardoukh C; Shimoni A; Chowers Y; Maor Y
    J Clin Immunol; 2013 Nov; 33(8):1395-402. PubMed ID: 24142230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased peripheral blood CD4+ T cell responses to deamidated but not to native gliadin in children with coeliac disease.
    Lammi A; Arikoski P; Vaarala O; Kinnunen T; Ilonen J
    Clin Exp Immunol; 2012 May; 168(2):207-14. PubMed ID: 22471282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the circulating, gliadin-specific CD4+ memory T cells in patients with celiac disease: linkage between memory function, gut homing and Th1 polarization.
    Ben-Horin S; Green PH; Bank I; Chess L; Goldstein I
    J Leukoc Biol; 2006 Apr; 79(4):676-85. PubMed ID: 16415168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
    Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
    Scand J Immunol; 1997 Sep; 46(3):103-9. PubMed ID: 9315123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local challenge of oral mucosa with gliadin in patients with coeliac disease.
    Lähteenoja H; Mäki M; Viander M; Toivanen A; Syrjänen S
    Clin Exp Immunol; 2000 Apr; 120(1):38-45. PubMed ID: 10759761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach.
    Carroccio A; Iannitto E; Di Prima L; Cirrincione S; Troncone R; Paparo F; Trapani LG; Gucciardi A; Averna MR; Montalto G; Notarbartolo A
    Dig Dis Sci; 2003 Aug; 48(8):1530-6. PubMed ID: 12924648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliadin-reactive T cells in Italian children from preventCD cohort at high risk of celiac disease.
    Camarca A; Auricchio R; Picascia S; Fierro O; Maglio M; Miele E; Malamisura B; Greco L; Troncone R; Gianfrani C
    Pediatr Allergy Immunol; 2017 Jun; 28(4):362-369. PubMed ID: 28339124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
    Lundin KE; Scott H; Hansen T; Paulsen G; Halstensen TS; Fausa O; Thorsby E; Sollid LM
    J Exp Med; 1993 Jul; 178(1):187-96. PubMed ID: 8315377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells.
    Gianfrani C; Levings MK; Sartirana C; Mazzarella G; Barba G; Zanzi D; Camarca A; Iaquinto G; Giardullo N; Auricchio S; Troncone R; Roncarolo MG
    J Immunol; 2006 Sep; 177(6):4178-86. PubMed ID: 16951383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro model of the pathogenesis of celiac disease.
    Oberhuber G; Schwarzenhofer M; Vogelsang H
    Dig Dis; 1998; 16(6):341-4. PubMed ID: 10207219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA restriction patterns of gliadin- and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients.
    Molberg O; Lundin KE; Nilsen EM; Scott H; Kett K; Brandtzaeg P; Thorsby E; Sollid LM
    Tissue Antigens; 1998 Nov; 52(5):407-15. PubMed ID: 9864029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiac disease association with CD8+ T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope.
    Gianfrani C; Troncone R; Mugione P; Cosentini E; De Pascale M; Faruolo C; Senger S; Terrazzano G; Southwood S; Auricchio S; Sette A
    J Immunol; 2003 Mar; 170(5):2719-26. PubMed ID: 12594302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8.
    Lundin KE; Scott H; Fausa O; Thorsby E; Sollid LM
    Hum Immunol; 1994 Dec; 41(4):285-91. PubMed ID: 7883596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.
    Ráki M; Dahal-Koirala S; Yu H; Korponay-Szabó IR; Gyimesi J; Castillejo G; Jahnsen J; Qiao SW; Sollid LM
    Gastroenterology; 2017 Sep; 153(3):787-798.e4. PubMed ID: 28535873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive and innate immune responses in celiac disease.
    Gianfrani C; Auricchio S; Troncone R
    Immunol Lett; 2005 Jul; 99(2):141-5. PubMed ID: 15876458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.
    Camarca A; Anderson RP; Mamone G; Fierro O; Facchiano A; Costantini S; Zanzi D; Sidney J; Auricchio S; Sette A; Troncone R; Gianfrani C
    J Immunol; 2009 Apr; 182(7):4158-66. PubMed ID: 19299713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.
    Freitag TL; Podojil JR; Pearson RM; Fokta FJ; Sahl C; Messing M; Andersson LC; Leskinen K; Saavalainen P; Hoover LI; Huang K; Phippard D; Maleki S; King NJC; Shea LD; Miller SD; Meri SK; Getts DR
    Gastroenterology; 2020 May; 158(6):1667-1681.e12. PubMed ID: 32032584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients.
    Maiuri L; Picarelli A; Boirivant M; Coletta S; Mazzilli MC; De Vincenzi M; Londei M; Auricchio S
    Gastroenterology; 1996 May; 110(5):1368-78. PubMed ID: 8613040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.